@article{zauber_cost-effectiveness_2010,
	title = {Cost-{Effectiveness} of {Colonoscopy}},
	volume = {20},
	issn = {1052-5157},
	url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145837/},
	doi = {10/cmd7s5},
	abstract = {We present a cost effectiveness analysis of colorectal cancer screening tests which have been recommended by the United States Preventive Services Task Force, American Cancer Sociey-GI Multisocieties-American College of Radiology, or the American College of Gastroenterology. This cost effectiveness analysis supports a common theme of the three Guideline groups that there are multiple acceptable colorectal cancer screening strategies (including colonoscopy). We show which recommended strategies are also cost effective given a range of willingnessto pay.per life-year gained. The set of cost effective strategies include tests which primarily detect cancer early (annual sensitive FOBTs (either guaiac or fecal immunochemical tests, but not Hemocccult II), as well as those which can prevent CRC (flexible sigmoidoscopy every 5 years with a frequent sensitive FOBT (but not flexible sigmoidoscopy as a stand-alone test), and colonoscopy). CT colonography was not a cost effective strategy. Stool DNA testing was not assessed in the analysis for this chapter.},
	number = {4},
	urldate = {2021-10-26},
	journal = {Gastrointestinal endoscopy clinics of North America},
	author = {Zauber, Ann G.},
	month = oct,
	year = {2010},
	pmid = {20889076},
	pmcid = {PMC4145837},
	note = {ZSCC: 0000059 },
	pages = {751--770},
}

{"_id":"ZE6W96PGf6jGwPGtc","bibbaseid":"zauber-costeffectivenessofcolonoscopy-2010","author_short":["Zauber, A. G."],"bibdata":{"bibtype":"article","type":"article","title":"Cost-Effectiveness of Colonoscopy","volume":"20","issn":"1052-5157","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145837/","doi":"10/cmd7s5","abstract":"We present a cost effectiveness analysis of colorectal cancer screening tests which have been recommended by the United States Preventive Services Task Force, American Cancer Sociey-GI Multisocieties-American College of Radiology, or the American College of Gastroenterology. This cost effectiveness analysis supports a common theme of the three Guideline groups that there are multiple acceptable colorectal cancer screening strategies (including colonoscopy). We show which recommended strategies are also cost effective given a range of willingnessto pay.per life-year gained. The set of cost effective strategies include tests which primarily detect cancer early (annual sensitive FOBTs (either guaiac or fecal immunochemical tests, but not Hemocccult II), as well as those which can prevent CRC (flexible sigmoidoscopy every 5 years with a frequent sensitive FOBT (but not flexible sigmoidoscopy as a stand-alone test), and colonoscopy). CT colonography was not a cost effective strategy. Stool DNA testing was not assessed in the analysis for this chapter.","number":"4","urldate":"2021-10-26","journal":"Gastrointestinal endoscopy clinics of North America","author":[{"propositions":[],"lastnames":["Zauber"],"firstnames":["Ann","G."],"suffixes":[]}],"month":"October","year":"2010","pmid":"20889076","pmcid":"PMC4145837","note":"ZSCC: 0000059 ","pages":"751–770","bibtex":"@article{zauber_cost-effectiveness_2010,\n\ttitle = {Cost-{Effectiveness} of {Colonoscopy}},\n\tvolume = {20},\n\tissn = {1052-5157},\n\turl = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145837/},\n\tdoi = {10/cmd7s5},\n\tabstract = {We present a cost effectiveness analysis of colorectal cancer screening tests which have been recommended by the United States Preventive Services Task Force, American Cancer Sociey-GI Multisocieties-American College of Radiology, or the American College of Gastroenterology. This cost effectiveness analysis supports a common theme of the three Guideline groups that there are multiple acceptable colorectal cancer screening strategies (including colonoscopy). We show which recommended strategies are also cost effective given a range of willingnessto pay.per life-year gained. The set of cost effective strategies include tests which primarily detect cancer early (annual sensitive FOBTs (either guaiac or fecal immunochemical tests, but not Hemocccult II), as well as those which can prevent CRC (flexible sigmoidoscopy every 5 years with a frequent sensitive FOBT (but not flexible sigmoidoscopy as a stand-alone test), and colonoscopy). CT colonography was not a cost effective strategy. Stool DNA testing was not assessed in the analysis for this chapter.},\n\tnumber = {4},\n\turldate = {2021-10-26},\n\tjournal = {Gastrointestinal endoscopy clinics of North America},\n\tauthor = {Zauber, Ann G.},\n\tmonth = oct,\n\tyear = {2010},\n\tpmid = {20889076},\n\tpmcid = {PMC4145837},\n\tnote = {ZSCC: 0000059 },\n\tpages = {751--770},\n}\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","author_short":["Zauber, A. G."],"key":"zauber_cost-effectiveness_2010","id":"zauber_cost-effectiveness_2010","bibbaseid":"zauber-costeffectivenessofcolonoscopy-2010","role":"author","urls":{"Paper":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145837/"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/nikitaj.greenidge","dataSources":["uXDRqZDxuAtbLLS2T"],"keywords":[],"search_terms":["cost","effectiveness","colonoscopy","zauber"],"title":"Cost-Effectiveness of Colonoscopy","year":2010}